FDA approves Imdelltra for patients with extensive-stage small cell lung cancer
The U.S. Food and Drug Administration on Thursday approved a new drug to treat patients with an advanced form of deadly lung ...
devdiscourse1h
Health News Roundup: US FDA approves Amgen drug for small cell lung cancer; US unveils proposal to ease restrictions on marijuana and more
Schedule one drugs, such as heroin, are considered highly addictive with no medical benefits, while schedule three drugs are ...
FDA approves Amgen drug for tough-to-treat form of lung cancer
Imdelltra, a bispecific antibody targeting a protein called DLL3, is cleared for use following chemotherapy in treating extensive-stage small cell lung cancer.
Cure Today5h
FDA Approves Imdelltra For Advanced SCLC
The Food and Drug Administration approved Imdelltra (tarlatamab) for the treatment of patients with advanced small cell lung ...
FDA APPROVES IMDELLTRA™ (TARLATAMAB-DLLE), THE FIRST AND ONLY T-CELL ENGAGER THERAPY FOR THE TREATMENT OF EXTENSIVE-STAGE SMALL CELL LUN…
Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved IMDELLTRA™ (tarlatamab-dlle ...
Monthly Prescribing Reference22h
Imdelltra Gets Accelerated Approval for Extensive-Stage SCLC
The Food and Drug Administration (FDA) has granted accelerated approval to Imdelltra (tarlatamab-dlle) for the treatment of adult patients with extensive stage small cell lung cancer (ES-SCLC ...
devdiscourse17h
Reuters Health News Summary
PX130, its other antibody, is in preclinical development for moderate to severe atopic dermatitis. AstraZeneca's COVID prevention drug cuts risk of disease in vulnerable patients AstraZeneca's ...
kffhealthnews10h
From KFF Health News - Latest Stories:
(Phillis, 5/17) The New York Times: FDA Approves Amgen Drug For Persistently Deadly Form Of Lung Cancer The Food and Drug ...
Medscape22h
Drug Shortages in the US: Causes and What the FDA Is Doing to Prevent New Shortages
What Types of Drugs Are in Short Supply and Why?